No single antidepressant is the safest for everyone, but sertraline consistently ranks among the best-tolerated options across the widest range of people. It has a favorable side effect profile, low overdose risk, minimal drug interactions compared to other SSRIs, and the most safety data in vulnerable populations including those with heart disease and those who are breastfeeding. That said, “safest” depends heavily on your specific situation: your age, other medications, pregnancy status, and which side effects matter most to you.
How Antidepressant Classes Compare on Safety
SSRIs and SNRIs have the lowest fatal toxicity indexes of any antidepressant class, meaning they carry the least risk of death in overdose. Among the older tricyclic antidepressants (TCAs), amitriptyline and doxepin have the highest overdose fatality rates. In head-to-head trials, SSRIs like paroxetine, citalopram, and sertraline cause fewer side effects than tricyclics, and fewer people stop taking them because of those side effects.
Within the SSRI class, most medications perform similarly on overall adverse events. Trials comparing sertraline, escitalopram, and paroxetine to fluoxetine found comparable rates of side effects and treatment dropout. The differences between SSRIs show up in more specific areas: drug interactions, heart safety, weight changes, sexual side effects, and how difficult they are to stop taking.
Heart Safety
For people with heart disease, sertraline is the preferred first-line antidepressant. It has few known cardiac side effects and does not interact with common heart medications. Fluoxetine and paroxetine are reasonable alternatives, though paroxetine carries other drawbacks discussed below.
Citalopram and escitalopram should generally be avoided in people with cardiac concerns because they can lengthen the QT interval (a measure of heart rhythm) in a dose-dependent way, raising the risk of dangerous arrhythmias. SNRIs like venlafaxine and duloxetine can increase blood pressure and cause arrhythmias, making them poor choices for people with existing heart conditions. Tricyclics are the worst performers here, increasing heart rate, disrupting rhythm, and causing drops in blood pressure on standing.
Newer agents like vortioxetine and agomelatine have not been linked to QT prolongation or other cardiac side effects, but less long-term data exists for them.
Sexual Side Effects
Sexual dysfunction is one of the most common reasons people want to switch antidepressants. SSRIs cause reduced desire, difficulty with arousal, or trouble reaching orgasm in 30% to 50% of people who take them. That’s a substantial proportion, and it affects quality of life enough that many people stop treatment.
Bupropion stands out here. It works through a completely different mechanism, affecting dopamine and norepinephrine rather than serotonin, and has an exceptionally low incidence of sexual side effects. It can even reverse sexual dysfunction caused by SSRIs. Mirtazapine and nefazodone also cause fewer sexual problems than standard SSRIs. If sexual function is your primary safety concern, bupropion is the strongest option, though it does carry trade-offs in other areas.
Weight and Metabolic Effects
Antidepressants vary by roughly 4 kilograms in their weight effects, with some promoting significant gain and others remaining weight-neutral. Paroxetine, duloxetine, desvenlafaxine, and venlafaxine have been associated with increases in total cholesterol. Duloxetine can also raise blood glucose levels. Bupropion and fluoxetine tend to be the most weight-neutral options, and bupropion sometimes causes modest weight loss.
Mirtazapine is known for increasing appetite and causing weight gain, which can be a benefit for people who are underweight or have lost their appetite from depression, but a drawback for others.
Overdose Risk
If safety in overdose is the concern, SSRIs and SNRIs are clearly the safest classes, with fatal toxicity indexes between 0.02 and 0.26. Tricyclics are far more dangerous when taken in excess. Notably, bupropion’s fatal toxicity index (0.27 to 0.43) is higher than other modern antidepressants and statistically comparable to older tricyclics like imipramine and nortriptyline. Bupropion overdoses are also more likely to cause serious illness or require emergency treatment. This is worth knowing if overdose risk is a relevant factor in your situation.
Safety for Older Adults
Depression treatment in people over 65 involves a distinct set of risks. Antidepressants can contribute to falls through dizziness, sedation, drops in blood pressure, and a condition called hyponatremia, where sodium levels in the blood fall too low. Even mild hyponatremia can cause confusion, weakness, and unsteadiness.
SSRI-induced hyponatremia occurs in 10% to 15% of older adults, with paroxetine carrying the highest incidence. Among SSRIs, sertraline, citalopram, and escitalopram have the lowest rates of both orthostatic hypotension (blood pressure dropping when you stand up) and hyponatremia. Mirtazapine also has a low hyponatremia risk, though its sedating effects can be a concern. Duloxetine and venlafaxine rank among the worst for both orthostatic hypotension and hyponatremia in older adults. Tricyclics double the risk of falls.
For older adults taking multiple medications, drug interactions become critical. Sertraline has substantially less potential to interfere with liver enzymes that process other drugs compared to paroxetine or fluoxetine, which are the strongest enzyme inhibitors among SSRIs. This makes sertraline a better fit for people on several medications.
Safety During Pregnancy and Breastfeeding
Sertraline and paroxetine are considered the most suitable first-line antidepressants during breastfeeding because of their low transfer into breast milk. Sertraline’s relative infant dose is just 0.5% to 3% of the maternal dose, and the drug typically doesn’t reach detectable levels in infant blood. Long-term studies of children exposed to antidepressants in utero have not revealed detrimental effects on intelligence, language, behavioral development, or neurological development.
Fluoxetine, despite being widely prescribed, transfers into breast milk at much higher rates. Infant plasma levels can reach concentrations comparable to the mother’s, and suspected adverse effects including irritability, decreased feeding, and watery stools have been reported in a small number of infants. Citalopram and venlafaxine also produce relatively high infant plasma levels.
Safety for Children and Teens
Among antidepressants, only fluoxetine (Prozac) is FDA-approved for treating major depression in children and adolescents. Sertraline, fluoxetine, and fluvoxamine are approved for obsessive-compulsive disorder in pediatric patients. All antidepressants carry a boxed warning about increased risk of suicidal thinking and behavior in young people, particularly during the first few months of treatment or when doses change. Close monitoring, including daily observation by family members, is a standard part of treatment for minors.
Discontinuation Difficulty
Some antidepressants cause a discontinuation syndrome when stopped, producing flu-like symptoms, dizziness, irritability, and sensations often described as “brain zaps.” The severity is closely tied to how quickly the drug leaves your body. Shorter half-life means faster elimination and a rougher withdrawal.
Venlafaxine has the shortest half-life of commonly prescribed antidepressants at just 3 to 13 hours, making it one of the hardest to stop. Paroxetine (21 to 24 hours) is similarly problematic. Fluoxetine, by contrast, has a half-life of 81 to 144 hours, and its active breakdown product stays in your system for 4 to 16 days. This built-in tapering effect makes fluoxetine the easiest antidepressant to discontinue. Sertraline falls in the middle at 22 to 36 hours, with an active metabolite that extends its effective duration.
Putting It All Together
Sertraline emerges as the most consistently safe choice across categories. It has low overdose toxicity, favorable cardiac safety, modest drug interaction potential, low transfer into breast milk, manageable discontinuation, and relatively low rates of hyponatremia in older adults. It’s not perfect: like all SSRIs, it causes sexual dysfunction in a significant number of people, and it can still cause discontinuation symptoms if stopped abruptly.
Bupropion is the safest choice for preserving sexual function but carries higher overdose risk. Fluoxetine is the easiest to stop and the only antidepressant approved for pediatric depression, but it transfers more readily into breast milk and is a strong enzyme inhibitor. Escitalopram is well-tolerated overall but poses QT prolongation concerns for those with heart conditions. Mirtazapine causes fewer sexual side effects and has low hyponatremia risk, but promotes weight gain and sedation. The safest antidepressant for you is the one that manages your depression effectively while avoiding the specific risks that matter most for your body and your life.